Nitric oxide from nanoparticles and applications to cardiovascular health

Pedro Cabrales, Adam J. Friedman, Joel M. Friedman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The current limitations of nitric oxide (NO) delivery systems has stimulated an extraordinary interest in the development of platforms that generate and release NO in a controlled and sustained manner, with a heavy emphasis on the treatment of cardiovascular disease states. This chapter describes the positive achievements of NO-releasing nanoparticles (NO-np) prepared using a novel platform based on hydrogel/glass hybrid nanoparticles capable of storing significant amounts of NO generated through thermal reduction of nitrite. The simplicity of the control release rate of NO from NO-np is regulated by its hydration when exposed to moisture; therefore, it allows the nanoparticles to slowly release therapeutic levels of NO. In a dose-dependent manner, infusion of NO-np has significant direct cardiovascular effect on physiological conditions, in terms of decreasing blood pressure, increasing exhaled NO, inducing vasodilation and increasing microvascular perfusion, during several hours post-infusion. Furthermore, the NO released by the NO-np prevents the inflammatory response regenerated by immune response to macroscopic external agents in the circulation. In pathological conditions related to an increase in acellular Hb in circulation, NO-np are able to prevent negative cardiovascular reactions related to NO scavenging by the acellular Hb. Furthermore, the NO-np are capable of preventing the cardiovascular collapse related to decrease in NO generation after severe hemorrhage without fluid resuscitation. These implications suggest that NO release from NO-np is advantageous over other NO-releasing compounds, because it does not depend on chemical decomposition or enzymatic catalysis. On the basis of the observed physiological properties, NO-np has clear potential as a therapeutic agent and as a research tool to increase our understanding of NO signaling mechanisms within the cardiovascular system.

Original languageEnglish (US)
Title of host publicationNanomedicine and the Cardiovascular System
PublisherCRC Press
Pages407-426
Number of pages20
ISBN (Electronic)9781439879894
ISBN (Print)9781578087266
StatePublished - Jan 1 2011

Fingerprint

Nitric oxide
Nanoparticles
Nitric Oxide
Health
Resuscitation
Cardiovascular system
Hydrogel
Scavenging
Blood pressure

ASJC Scopus subject areas

  • Medicine(all)
  • Engineering(all)

Cite this

Cabrales, P., Friedman, A. J., & Friedman, J. M. (2011). Nitric oxide from nanoparticles and applications to cardiovascular health. In Nanomedicine and the Cardiovascular System (pp. 407-426). CRC Press.

Nitric oxide from nanoparticles and applications to cardiovascular health. / Cabrales, Pedro; Friedman, Adam J.; Friedman, Joel M.

Nanomedicine and the Cardiovascular System. CRC Press, 2011. p. 407-426.

Research output: Chapter in Book/Report/Conference proceedingChapter

Cabrales, P, Friedman, AJ & Friedman, JM 2011, Nitric oxide from nanoparticles and applications to cardiovascular health. in Nanomedicine and the Cardiovascular System. CRC Press, pp. 407-426.
Cabrales P, Friedman AJ, Friedman JM. Nitric oxide from nanoparticles and applications to cardiovascular health. In Nanomedicine and the Cardiovascular System. CRC Press. 2011. p. 407-426
Cabrales, Pedro ; Friedman, Adam J. ; Friedman, Joel M. / Nitric oxide from nanoparticles and applications to cardiovascular health. Nanomedicine and the Cardiovascular System. CRC Press, 2011. pp. 407-426
@inbook{8dcec86d144c4b81832222231188ef62,
title = "Nitric oxide from nanoparticles and applications to cardiovascular health",
abstract = "The current limitations of nitric oxide (NO) delivery systems has stimulated an extraordinary interest in the development of platforms that generate and release NO in a controlled and sustained manner, with a heavy emphasis on the treatment of cardiovascular disease states. This chapter describes the positive achievements of NO-releasing nanoparticles (NO-np) prepared using a novel platform based on hydrogel/glass hybrid nanoparticles capable of storing significant amounts of NO generated through thermal reduction of nitrite. The simplicity of the control release rate of NO from NO-np is regulated by its hydration when exposed to moisture; therefore, it allows the nanoparticles to slowly release therapeutic levels of NO. In a dose-dependent manner, infusion of NO-np has significant direct cardiovascular effect on physiological conditions, in terms of decreasing blood pressure, increasing exhaled NO, inducing vasodilation and increasing microvascular perfusion, during several hours post-infusion. Furthermore, the NO released by the NO-np prevents the inflammatory response regenerated by immune response to macroscopic external agents in the circulation. In pathological conditions related to an increase in acellular Hb in circulation, NO-np are able to prevent negative cardiovascular reactions related to NO scavenging by the acellular Hb. Furthermore, the NO-np are capable of preventing the cardiovascular collapse related to decrease in NO generation after severe hemorrhage without fluid resuscitation. These implications suggest that NO release from NO-np is advantageous over other NO-releasing compounds, because it does not depend on chemical decomposition or enzymatic catalysis. On the basis of the observed physiological properties, NO-np has clear potential as a therapeutic agent and as a research tool to increase our understanding of NO signaling mechanisms within the cardiovascular system.",
author = "Pedro Cabrales and Friedman, {Adam J.} and Friedman, {Joel M.}",
year = "2011",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781578087266",
pages = "407--426",
booktitle = "Nanomedicine and the Cardiovascular System",
publisher = "CRC Press",

}

TY - CHAP

T1 - Nitric oxide from nanoparticles and applications to cardiovascular health

AU - Cabrales, Pedro

AU - Friedman, Adam J.

AU - Friedman, Joel M.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - The current limitations of nitric oxide (NO) delivery systems has stimulated an extraordinary interest in the development of platforms that generate and release NO in a controlled and sustained manner, with a heavy emphasis on the treatment of cardiovascular disease states. This chapter describes the positive achievements of NO-releasing nanoparticles (NO-np) prepared using a novel platform based on hydrogel/glass hybrid nanoparticles capable of storing significant amounts of NO generated through thermal reduction of nitrite. The simplicity of the control release rate of NO from NO-np is regulated by its hydration when exposed to moisture; therefore, it allows the nanoparticles to slowly release therapeutic levels of NO. In a dose-dependent manner, infusion of NO-np has significant direct cardiovascular effect on physiological conditions, in terms of decreasing blood pressure, increasing exhaled NO, inducing vasodilation and increasing microvascular perfusion, during several hours post-infusion. Furthermore, the NO released by the NO-np prevents the inflammatory response regenerated by immune response to macroscopic external agents in the circulation. In pathological conditions related to an increase in acellular Hb in circulation, NO-np are able to prevent negative cardiovascular reactions related to NO scavenging by the acellular Hb. Furthermore, the NO-np are capable of preventing the cardiovascular collapse related to decrease in NO generation after severe hemorrhage without fluid resuscitation. These implications suggest that NO release from NO-np is advantageous over other NO-releasing compounds, because it does not depend on chemical decomposition or enzymatic catalysis. On the basis of the observed physiological properties, NO-np has clear potential as a therapeutic agent and as a research tool to increase our understanding of NO signaling mechanisms within the cardiovascular system.

AB - The current limitations of nitric oxide (NO) delivery systems has stimulated an extraordinary interest in the development of platforms that generate and release NO in a controlled and sustained manner, with a heavy emphasis on the treatment of cardiovascular disease states. This chapter describes the positive achievements of NO-releasing nanoparticles (NO-np) prepared using a novel platform based on hydrogel/glass hybrid nanoparticles capable of storing significant amounts of NO generated through thermal reduction of nitrite. The simplicity of the control release rate of NO from NO-np is regulated by its hydration when exposed to moisture; therefore, it allows the nanoparticles to slowly release therapeutic levels of NO. In a dose-dependent manner, infusion of NO-np has significant direct cardiovascular effect on physiological conditions, in terms of decreasing blood pressure, increasing exhaled NO, inducing vasodilation and increasing microvascular perfusion, during several hours post-infusion. Furthermore, the NO released by the NO-np prevents the inflammatory response regenerated by immune response to macroscopic external agents in the circulation. In pathological conditions related to an increase in acellular Hb in circulation, NO-np are able to prevent negative cardiovascular reactions related to NO scavenging by the acellular Hb. Furthermore, the NO-np are capable of preventing the cardiovascular collapse related to decrease in NO generation after severe hemorrhage without fluid resuscitation. These implications suggest that NO release from NO-np is advantageous over other NO-releasing compounds, because it does not depend on chemical decomposition or enzymatic catalysis. On the basis of the observed physiological properties, NO-np has clear potential as a therapeutic agent and as a research tool to increase our understanding of NO signaling mechanisms within the cardiovascular system.

UR - http://www.scopus.com/inward/record.url?scp=85059588538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059588538&partnerID=8YFLogxK

M3 - Chapter

SN - 9781578087266

SP - 407

EP - 426

BT - Nanomedicine and the Cardiovascular System

PB - CRC Press

ER -